Biotech stocks could be about to do something big (Market Video Update)

After slumping with underperformance, 2022 promises to be more more fertile ground for biotech stocks and biotech ETFs such as IBB and XBI. While the price action is beginning to look better, there is one driving tail wind that could really propel these stock higher in 2022.

Get Serge’s Daily Trading Tips

Subscribe now and get clear, actionable, and relevant trade ideas!

By giving your contact info you agree to receive future emails from The Steady Trader including educational and promotional content. By providing your mobile phone number and clicking on the above “Subscribe” button, you agree to receive automated promotional messages from us via SMS. By opting into our SMS Program, you agree to our Terms and Conditions and Privacy Policy.